Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan.

about

FAM83D, a microtubule-associated protein, promotes tumor growth and progression of human gastric cancer.

P2860

Q44415873-8321CF3E-3B30-46ED-8623-5A06A6335649

P2860

Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan.

Item

http://www.wikidata.org/entity/Q38986946

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Intraperitoneal chemotherapy f ...... ence from Singapore and Japan.

@en

type

Item

label

Intraperitoneal chemotherapy f ...... ence from Singapore and Japan.

@en

prefLabel

Intraperitoneal chemotherapy f ...... ence from Singapore and Japan.

@en

P1476

Intraperitoneal chemotherapy f ...... ience from Singapore and Japan

@en

P2093

Koji Kono

http://www.w3.org/2001/XMLSchema#string

Seiichi Takenoshita

http://www.w3.org/2001/XMLSchema#string

Shinji Ohki

http://www.w3.org/2001/XMLSchema#string

Tomoyuki Momma

http://www.w3.org/2001/XMLSchema#string

Wei-Peng Yong

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study

A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer.

Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure.

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.

Disparities in gastric cancer chemotherapy between the East and West.

Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer.

Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis.

Chemotherapy for metastatic disease: review from JCOG trials.

P2888

s10120-016-0660-y

P304

122-127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10120-016-0660-Y

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Asim Shabbir

Hirokazu Okayama

Jimmy So

P577

2016-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1032238319

http://www.w3.org/2001/XMLSchema#string

P698

27766496

http://www.w3.org/2001/XMLSchema#string

P921

Singapore

Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan.

about

P2860

P2860

Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921